- EFSA (2015): Scientific Opinion on the Safety of Caffeine, EFSA Journal, 13(5):4102.
- Wasim S. (2020) Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature. Cureus, 12(8):e9578.
- Ran L.S. et al. (2021) Alcohol, Coffee and Tea Intake and the Risk of Cognitive Deficits: a Dose-Response Meta-Analysis. Epidemiol Psychiatr, 30:e13.
- Yelanchezian Y.M.M. (2022) Neuroprotective Effect of Caffeine in Alzheimer's Disease. Molecules, 27(12):3737.
- Shao C. et al. (2021) Coffee Consumption and Stroke Risk: Evidence from a Systematic Review and Meta-Analysis of more than 2.4 Million Men and Women, J Stroke Cerebrovasc Dis, 30(1):105452.
- Chan L. et al. (2021) Coffee consumption and the risk of cerebrovascular disease: a meta-analysis of prospective cohort studies. BMC Neurol, 21(1):380.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011): Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA Journal, 9(4):2054.
- Fiani B. et al. (2021) The neurophysiology of caffeine as a central nervous system stimulant and the resultant effects on cognitive function. Cureus, 13(5):e15032
- McLellan T.M. et al. (2016): A review of caffeine’s effects on cognitive, physical and occupational performance. Neuro & Biobehav Revs, 71:294-312.
- Chen J.Q.A. ET AL (2020) Associations Between Caffeine Consumption, Cognitive Decline, and Dementia. J Alzheimers Dis, 78(4):1519-1546.
- Larsson S.C., Orsini N. (2018): Coffee Consumption and Risk of Dementia and Alzheimer’s Disease: A Dose-response Meta-Analysis of Prospective Studies. Nutrients, 10 (10).
- Cornelis M.C. et al. (2020) Caffeinated coffee and tea consumption, genetic variation and cognitive function in the UK Biobank. J Nutr, 150(8):2164-2174
- Li X. et al. (2022) Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019. Front Aging Neurosci, 14: 937486
- Alzheimer Europe (2019): ‘Alzheimer’s disease. Available at: http://www.alzheimer-europe.org/EN/Dementia/Alzheimer-s-disease
- Alzheimer Europe (2019): ‘Who is affected by Alzheimer’s disease?’ Available at: http://www.alzheimer-europe.org/Dementia/Alzheimer-s-disease/Who-is-affected-by-Alzheimer-s-disease
- GBD Dementia Collaborators (2019): Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 18(1): 88-106.
- Zhou X., Zhang L. (2021) The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease. Oxid Med Cell Longev, 2021: 5568011.
- Wierzejska R. (2017): Can coffee consumption lower the risk of Alzheimer’s disease and Parkinson’s disease? A literature review. Arch Med Sci, Volume 13 (3) :507-514.
- Larsson S.C. et al. (2017): Modifiable pathways in Alzheimer’ s disease: Mendelian randomisation analysis. BMJ, 359:j5375.
- Janitschke D. et al (2021) Methylxanthines and Neurodegenerative Diseases: An Update, Molecules, 13(3):803.
- Madeira M.H. et al. (2017): Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases. Mediators Inflamm, 2017:4761081.
- Socala K. et al. (2021) Neuroprotective Effects of Coffee Bioactive Compounds: A Review. Int J Mol Sci, 22(1):107.
- World Health Organisation (2023) Parkinson Disease Factsheet. Available at https://www.who.int/news-room/fact-sheets/detail/parkinson-disease
- Hong C.T. (2020) The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis. Nutrients,12(6):1860.
- Ko T.K. (2023) Does Drinking Coffee Reduce the Incidence of Parkinson's Disease? Cureus,15(1):e34296.
- Kim I.Y. et al. (2017): Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use, J Parkinsons Dis, 7(4):677-684.
- Bisaglia, M. (2022) Mediterranean Diet and Parkinson’s Disease. Int J Mol Sci, 24(1):42.
- Chuang Y.H. et al. (2017): Gene-Environment Interaction in Parkinson’s Disease: Coffee, ADORA2A, and CYP1A2. Neuroepidemiol, 47(3-4):192-200.
- Kim I.Y. et al. (2018): Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson’s disease risk. Mov Disord, 33(3):414-420.
- World Stroke Organisation (2022) Global Stroke Factsheet. Available at https://www.worldstroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf
- Deng C. et al. (2017): Stroke and food groups: an overview of systematic reviews and meta-analyses. Pub Health Nutr, 21(4):766-776.
